Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-23

Clinical Trial Update: A Study for the Transdermal Application of Teriparatide [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a transdermal teriparatide formulation for osteoporosis; the trial is completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2012-10-23